Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors using a platform of primary human cell based disease models, BioMAP® systems
Predictive Models for Mechanism of Action Classification from Phenotypic Assay Data – Application to Phenotypic Drug Discovery
